Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy
| Author | Pouya Safarzadeh Kozani | en |
| Author | Pooria Safarzadeh Kozani | en |
| Author | Fatemeh Rahbarizadeh | en |
| Orcid | Pouya Safarzadeh Kozani [0000-0002-2602-3871] | en |
| Orcid | Pooria Safarzadeh Kozani [0000-0002-9901-7851] | en |
| Orcid | Fatemeh Rahbarizadeh [0000-0003-0890-8366] | en |
| Issued Date | 2021-02-28 | en |
| Abstract | Nucleolin is a protein abundantly present in the nucleolus, but its expression on the surface of cells is potentially associated with various types of malignancies. So far, several nucleolin-targeting strategies, including the nucleolin-targeting peptide, anti-nucleolin pseudopeptides, anti-nucleolin antibodies, and the anti-nucleolin aptamer, AS1411, have been developed and investigated in different types of studies. The AS1411 aptamer has been known as the outstanding approach for targeting nucleolin with superior specificity and therapeutic potential in comparison with other targeting strategies. In this review, we highlight different nucleolin-targeting strategies for the targeted delivery of chemotherapeutic drugs, proteins with therapeutic potential, and toxins. | en |
| DOI | https://doi.org/10.5812/tms.113773 | en |
| Keyword | Nucleolin | en |
| Keyword | AS1411 | en |
| Keyword | Aptamer | en |
| Keyword | Cancer | en |
| Keyword | Nanoparticles | en |
| Keyword | Drug Delivery | en |
| Publisher | Brieflands | en |
| Title | Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- tms-1-1-113773.pdf
- Size:
- 138.3 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF